Subscribe to RSS
DOI: 10.1055/s-2007-968027
New Benzothiazole and Benzoxazole Scaffolds from the Ugi-Smiles Couplings of Heterocyclic Thiols
Publication History
Publication Date:
07 February 2007 (online)
Abstract
New four-component benzoxazole and benzothiazole scaffolds were obtained via an Ugi-Smiles coupling of 2-mercapto benzoxazole and 2-mercapto benzothiazole derivatives with isocyanides, aldehydes and primary amines. The 2-mercapto benzimidazoles tested were not reactive under similar conditions as well as the analogous 2-hydroxy benzoxazoles and 2-hydroxy benzothiazoles.
Key words
benzothiazole - benzoxazole - multicomponent reaction - thioamides
- 1
El Kaim L.Grimaud L.Oble J. Angew. Chem. Int. Ed. 2005, 117: 7961 - 2
El Kaim L.Gizolme M.Grimaud L.Oble J. Org. Lett. 2006, 8: 4019 - For some benzothiazole drug targets, see:
-
3a
Haugwitz RD.Angel RG.Jacobs GA.Maurer BV.Narayanan VL.Cruthers LR.Szanto J. J. Med. Chem. 1982, 25: 969 -
3b
Hori N.Tsukamoto G.Imamura A.Ohashi M.Saito T.Yoshino K. Chem. Pharm. Bull. 1992, 40: 2387 -
3c
Gaillard P.Jeanclaude-Etter I.Ardissone V.Arkinstall S.Cambet Y.Camps M.Chabert C.Church D.Cirillo R.Gretener D.Halazy S.Nichols A.Szyndralewiez C.Vitte P.-A.Gotteland J. J. Med. Chem. 2005, 48: 4596-4607 - For some benzoxazole drugs, see:
-
3d
Brown RN.Cameron R.Chalmers DK.Hamilton S.Luttick A.Krippner GY.McConnell DB.Nearn R.Stanislawski PC.Tucker SP.Watson KG. Bioorg. Med. Chem. Lett. 2005, 15: 2051 -
3e
Manas ES.Unwalla RJ.Xu ZB.Malamas MS.Miller CP.Harris HA.Hsiao C.Akopian T.Hum W.-T.Malakian K.Wolfrom S.Bapat A.Bhat RA.Stahl ML.Somers WS.Alvarez JC. J. Am. Chem. Soc. 2004, 126: 15106 -
3f
Malamas MS.Manas ES.McDevitt RE.Gunawan I.Xu ZB.Collini MD.Miller CP.Dinh T.Henderson RA.Keith JC.Harris HA. J. Med. Chem. 2004, 47: 5021 -
3g
Yoshida S.Shiokawa S.Kawano K.Ito T.Murakami H.Suzuki H.Sato Y. J. Med. Chem. 2005, 48: 7075 -
3h
Easmon J.Pürstinger G.Thies K.Heinisch G.Hofmann J. J. Med. Chem. 2006, 49: in press -
4a
Schuart J.Mueller HK. Pharmazie 1975, 30: 155 -
4b
Wade JJ.Hegel RF.Toso CB. J. Org. Chem. 1979, 44: 1811 -
4c
Blanc M.Tamir A.Aubriot S.Michel MC.Bouzoubaa M.Leclerc G.Demenge P. J. Med. Chem. 1998, 41: 1613 - SO2 leaving group:
-
5a
Hoggarth E. J. Chem. Soc. 1949, 3311 -
5b
Hwang JY.Gong Y. J. Comb. Chem. 2006, 8: 297 - Cl leaving group:
-
5c
Advani SP.Sam J. J. Pharm. Sci. 1968, 57: 1693 -
5d
Haviv F.Ratajczyk JD.DeNet RW.Kerdesky FA.Walters RL.Schmidt SP.Holms JH.Young PR.Carter GW. J. Med. Chem. 1988, 31: 1719 - 6
Katsura Y.Nishino S.Inoue Y.Tomoi M.Takasugi H. Chem. Pharm. Bull. 1992, 2: 371 - 7
Richter M.Herrmann C.Augustin M. J. Prakt. Chem. 1980, 322: 434 - 8
Evindar G.Batey RA. J. Org. Chem. 2006, 71: 1802 -
9a
Jordan AD.Luo C.Reitz AB. J. Org. Chem. 2003, 68: 8693 -
9b
Hugerschoff H. Ber. Dtsch. Chem. Ges. 1901, 34: 3130 -
10a
Choi S.Park HJ.Lee SK.Kim SW.Han G.Choo HP. Bioorg. Med. Chem. 2006, 4: 1229 -
10b
Lee CL.Lam Y.Lee S. Tetrahedron Lett. 2001, 42: 109 -
10c
Berta D.Villa M.Vulpetti A.Felder ER. Tetrahedron 2005, 61: 10801 -
10d
See ref. 5b.
-
12a
Boyd GV. Oxazoles and their Benzo Derivatives, In Comprehensive Heterocyclic Chemistry Vol. 6:Katrizky AR. Pergamon; Oxford: 1997. p.178-233 -
12b
Metzger JV. Thiazoles and their Benzo Derivatives, In Comprehensive Heterocyclic Chemistry Vol. 6:Katrizky AR. Pergamon; Oxford: 1997. p.236-330 - For general reviews on Ugi-based multicomponent reactions, see:
-
13a
Banfi L.Riva R. Org. React. 2005, 65: 1 -
13b
Zhu J. Eur. J. Org. Chem. 2003, 1133 -
13c
Ugi I.Werner B.Dömling A. Molecules 2003, 8: 53 -
13d
Hulme C.Gore V. Curr. Med. Chem. 2003, 10: 51 -
13e
Bienaymé H.Hulme C.Oddon G.Schmitt P. Chem. Eur. J. 2000, 6: 3321 -
13f
Dömling A.Ugi I. Angew. Chem. Int. Ed. 2000, 39: 3168 -
13g
Dömling A. Chem. Rev. 2006, 106: 17
References and Notes
Preparation of Thioamide 4b; Typical Procedure
To a 1 M solution of carbonyl compound 1b in toluene were added the amine 2a (1.0 equiv), the isocyanide 3a (1.0 equiv)and the mercapto benzoxazole (1.0 equiv). The resulting mixture was stirred at 50 °C under an inert atmosphere for 2 d and concentrated in vacuo. The crude product was then purified by flash chromatography on silica gel to give the desired adduct 4b.
1H NMR (400 MHz, CDCl3): δ = 10.00 (br s, 1 H), 7.38-7.28 (m, 6 H), 7.24 (td, 1 H, J = 7.8, 1.3 Hz), 7.12 (td, 1 H, J = 7.8, 1.3 Hz), 4.96 (d, 1 H, J = 16.2 Hz), 4.76 (d, 1 H, J = 16.2 Hz), 4.53 (t, 1 H, J = 7.6 Hz), 2.36-2.24 (m, 1 H), 2.12-2.02 (m, 1 H), 1.52 (s, 9 H), 0.82 (t, 3 H, J = 7.3 Hz). 13C NMR (100.6 MHz, CDCl3): δ = 199.2, 162.8, 148.9, 142.3, 136.5, 133.9, 129.7, 129.1, 124.8, 121.8, 116.5, 109.7, 74.1, 56.0, 51.7, 27.5, 24.2, 11.3. IR (thin film): 2965, 2930, 2349, 1625, 1563, 1458, 1362, 1245, 1210, 1014 cm-1. MS (DI, CI NH3): m/z = 416 [M + H+]. HRMS: m/z calcd for C22H26ClN3OS: 415.1485; found: 415.1471.